| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |